What is Crossbow Therapeutics worth?
$125.0Mlast known valuation
Crossbow Therapeutics last raised $30.3M in its Early Stage VC (Sep 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Crossbow Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Early Stage VC | $30.3M | ▮ | ▮ |
| Mar 2023 | Early Stage VC | $37.6M | ▮ | ▮ |
How Crossbow Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Crossbow Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Crossbow Therapeutics worth?
- Crossbow Therapeutics's last known valuation is $125.0M.
- How much has Crossbow Therapeutics raised?
- Crossbow Therapeutics has raised $198.3M in total funding across 2 recorded rounds.
- When did Crossbow Therapeutics last raise?
- Crossbow Therapeutics last raised in Sep 2025 (Early Stage VC), raising $30.3M.